About this event
The 5th IPOPI webinar will focus on explaining hyperinflammation in primary immunodeficiency patients and discuss how this differs from patients infected with COVID-19. This topic will be presented by Professor Frédéric Rieux-Laucat.
This webinar is directed towards medical professionals with an interest in PID as well as patient group leaders and PID patients. The scope of the webinar will be clinically oriented, and suitable for a non-medical audience as well.
You can access the webinar through your browser or through a mobile devices. It will be recorded and can be accessed for streaming on IPOPI TV after the date.
Hosted by
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) is an international not for profit organisation dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide.
Professor Frédéric Rieux-Laucat is Director of Research at Inserm and heads the Lab of Immunogenetics of Pediatric Autoimmune Diseases at the Imagine Institute.
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) is an international not for profit organisation dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide.